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Abstract
Background—This study aims to assess the relationship of body mass index (BMI) status with 
respiratory conditions, asthma, and chronic obstructive pulmonary disease (COPD) in a state 
population.
Methods—Self-reported data from 11,868 adults aged ≥18 years in the 2012 South Carolina 
Behavioral Risk Factor Surveillance System telephone survey were analyzed using multivariable 
logistic regression that accounted for the complex sampling design and adjusted for sex, age, race/
ethnicity, education, smoking status, physical inactivity, and cancer history.
Results—The distribution of BMI (kg/m2) was 1.5% for underweight (<18.5), 32.3% for normal 
weight (18.5-24.9), 34.6% for overweight (25.0-29.9), 26.5% for obese (30.0-39.9), and 5.1% for 
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morbidly obese (≥40.0). Among respondents, 10.0% had frequent productive cough, 4.3% had 
frequent shortness of breath (SOB), 7.3% strongly agreed that SOB affected physical activity, 
8.4% had current asthma, and 7.4% had COPD. Adults at extremes of body weight were more 
likely to report having asthma or COPD, and to report respiratory conditions. Age-adjusted U-
shaped relationships of BMI categories with current asthma and strongly agreeing that SOB 
affected physical activity, but not U-shaped relationship with COPD, persisted after controlling for 
the covariates (p<0.001). Morbidly obese but not underweight or obese respondents were 
significantly more likely to have frequent productive cough and frequent SOB than normal weight 
adults after adjustment.
Conclusion—Our data confirm that both underweight and obesity are associated with current 
asthma and obesity with COPD. Increased emphasis on exercise and nutrition may improve 
respiratory conditions.
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Body Mass Index; chronic obstructive pulmonary disease; asthma; respiratory conditions; 
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Introduction
A large number of studies support that obesity is a major risk factor for respiratory 
symptoms and chronic conditions such as cardiovascular disease, asthma, and chronic 
obstructive pulmonary disease (COPD) [1-6]. In addition, a few studies reported that 
underweight was also associated with reduced respiratory function and asthma [7-9]. 
Breathlessness and exercise intolerance are common in clinical studies of patients with 
obesity and/or respiratory conditions [7,10-14]. A U-shaped relationship of body mass index 
(BMI) was reported with dyspnea in men and with symptomatic airway hyper-
responsiveness, which are asthma-related symptoms that include wheezing and dyspnea in 
men [7,8,15,16]. Other studies have not observed a significant relationship between BMI 
and airway hyper-responsiveness [17,18]. However, the existing research on the 
relationships between extremes of BMI with respiratory conditions and respiratory 
symptoms is limited—often because of small sample sizes in clinical studies or exclusion of 
underweight participants or not distinguishing between obesity and morbid obesity 
[7-9,15,16,18-20].
This study aims to assess the relationship of BMI levels with self-reported respiratory 
symptoms and respiratory conditions using the 2012 population-based South Carolina 
Behavioral Risk Factor Surveillance System (BRFSS) survey. While the BRFSS relies on 
self-reported characteristics rather than clinical measurements, it provides the opportunity to 
assess potential relationships in a large general population, which is better representative of 
the heterogeneous types of patients that would enter a physician's office than subjects 
commonly selected for clinical studies.
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Material and Methods
The BRFSS is an annual random-digital-dialed telephone survey that is conducted by state 
health departments in collaboration with the Centers for Disease Control and Prevention 
(CDC) in all 50 states, the District of Columbia, and US territories. The respondents in 
households with either landline or cellular telephones were selected using a complex 
stratified sampling method and new weighting procedures have been adopted since 2011 in 
order to better reflect the nation's health status (http://www.cdc.gov/surveillancepractice/
reports/brfss/brfss.html). The South Carolina (SC) BRFSS in 2012 included questions about 
socio-demographic characteristics, risk behaviors, chronic diseases, respiratory symptoms, 
self-reported height, and self-reported weight. The combined response rate (the number of 
respondents who completed the survey as a proportion of all eligible and likely-eligible 
persons using the American Association of Public Opinion Research Response Rate 
Formula #4) was 48.6% for SC respondents aged ≥18 years in the survey (http://
www.cdc.gov/brfss/annual_data/2012/pdf/
SummaryDataQualityReport2012_20130712.pdf). The survey data do not contain personal 
identification information and this study is a secondary data analysis, which is exempt from 
Institutional Review Board review.
Of 12,795 respondents aged ≥18 years in the 2012 SC BRFSS, 11,868 (92.8%) adults who 
provided complete information were included in this study after exclusion of those missing 
data on sex, age, race/ethnicity, education, body weight and/or body height, smoking status, 
physical inactivity, cancer history, asthma, or COPD.
Respiratory Conditions
A history of COPD was defined as an affirmative response to the question “Has a doctor, 
nurse, or other health professional ever told you that you have chronic obstructive 
pulmonary disease or COPD, emphysema or chronic bronchitis?” Over 76.4% of 
respondents with self-reported COPD also reported having had a breathing test such as 
spirometry. Current asthma was defined for persons who answered in the affirmative to the 
following two questions: “Has a doctor, nurse, or other health professional ever told you that 
you have asthma?” and “Do you still have asthma?” Persons who reported ‘don’t know/not 
sure' as a response to either COPD or asthma were defined as not having been diagnosed 
with that condition. Three respiratory symptom questions are described as follows: 1)“How 
often do you cough up mucus or phlegm?” A frequent productive cough was defined when 
respondents chose either ‘everyday’ or ‘most days a week’ to compare with respondents 
with responses of ‘a few days a month’, ‘only with occasional colds or chest infections’, or 
‘never’; 2)“During the past 30 days, how often did you feel short of breath (SOB)?” 
Frequent SOB was defined when respondents chose either ‘all the time’ or ‘most of the 
time’ to compare to respondents with other responses; and 3)“Thinking about your physical 
activity during the last 12 months, do you agree slightly or strongly, or disagree slightly or 
strongly with the following statement: I do less now than I used to because of my breathing 
problems”, we compared ‘strongly agree’ to respondents with the other responses.
Liu et al. Page 3
Respir Med. Author manuscript; available in PMC 2016 July 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Body Mass Index (BMI)
All respondents were asked “about how much (pounds) do you weigh without shoes” and 
“About how tall (feet and inches) are you without shoes?” BMI was then calculated as 
kilograms/meter2 and grouped into five categories: underweight (<18.5 kg/m2), normal 
weight (18.5-24.9 kg/m2), overweight (25.0-25.9 kg/m2), obese (30.0-39.9 kg/m2), and 
morbidly obese (≥40.0 kg/m2).
Covariates
Selected socio-demographic characteristics included age (18-24, 25-34, 35-44, 45-64, or ≥65 
years), sex, and race/ethnicity (non-Hispanic white, non-Hispanic black, Hispanic, or non-
Hispanic other). Respondents were asked the highest grade or year of school completed and 
responses were grouped into less than a high school diploma (≤grade 11), high school 
graduate or equivalent (grade 12 or general education development certificate), and at least 
some college (1 to 3 years college or college ≥4 years).
A history of cancer was defined as an affirmative response to the question “Has a doctor, 
nurse, or other health professional ever told you that you had cancer (excluding skin 
cancer)?” Cancer is often highly associated with underweight so we included a history of 
cancer as a confounder in the model to ascertain whether underweight status was explained 
by comorbid cancer. For these analyses, never smokers were defined by a negative response 
to the first tobacco question “Have you smoked at least 100 cigarettes in your entire life?” 
Former smokers were defined by an affirmative response to the first tobacco question and a 
response of “not at all” to a second tobacco use question, “Do you now smoke cigarettes 
every day, some days, or not at all?” Current smokers were defined by an affirmative 
response to the first question and a response of “every day” or “some days” to the second. 
Physical inactivity was defined by a negative response to “During the past month, other than 
your regular job, did you participate in any physical activities or exercises such as running, 
calisthenics, golf, gardening, or walking for exercise?”
Statistical Analyses
First, we examined the distributions of selected characteristics among study respondents 
overall and then by levels of BMI. We also compared the distribution of BMI levels for 
respondents defined by COPD status and current asthma status. The age-adjusted prevalence 
and 95% confidence interval (CI) of respiratory symptoms, COPD, and asthma by BMI 
levels were obtained from separate logistic regression models that included age as the 
covariate. Finally, we assessed the adjusted prevalence ratios (PR) and 95% CI for the 
likelihood of having respiratory symptoms or respiratory conditions associated with BMI 
levels using a multivariable logistic regression model that included sex, age, race/ethnicity, 
education, current smoking status, and physical inactivity as covariates. We repeated the 
multivariable logistic analyses with the addition of cancer history as a covariate to determine 
whether cancer may confound the relationship, particularly among underweight persons. 
The complex sampling design in this study requires a statistical software that can take into 
account stratification, clustering, and sample weights to obtain more representative estimates 
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of population prevalence and the associated CIs. Therefore, SAS-callable SUDAAN 
(Release 10.0.1, Research Triangle Institute, NC) was used to analyze the data.
Results
Table 1 shows the distribution of selected characteristics among 11,868 adults aged ≥18 
years. Among SC adults, 1.5% were underweight, 32.3% were normal weight, 34.6% were 
overweight, 26.5% were obese, 5.1% were morbidly obese, 23.0% were current smokers, 
24.4% reported physical inactivity in the past month, 10.0% had a frequent productive 
cough, 4.3% had SOB, 7.3% strongly agreed that SOB affected physical activity, 8.4% had 
current asthma, 7.4% had COPD, and 6.6% had a history of cancer. Only 2.6% of the study 
population had both COPD and asthma.
Figure 1 demonstrates that respondents who reported having COPD had a significantly 
higher percentage of obesity (32.0% vs. 26.1%, p=0.01) and morbid obesity (10.3% vs. 
4.7%, p<0.001) but not underweight status (2.4% vs. 1.4%, p=0.10) than those without 
COPD. Similarly, a significantly higher percentage of obesity (36.8% vs. 25.6%, p<0.001) 
and morbid obesity (11.5% vs. 4.5%, p<0.001) but not underweight (2.6% vs. 1.4%, p=0.12) 
was also reported among respondents who had current asthma than those without current 
asthma.
The percentage of selected characteristics by BMI levels are presented in Table 2. Compared 
to persons with normal weight, underweight adults were significantly (p<0.05) more likely 
to have current asthma, COPD, and to strongly agree that SOB affects physical activity. 
Obese or morbidly obese adults were significantly (p<0.05) more likely than adults with 
normal weight to have asthma, COPD, physical inactivity, frequent SOB, and to strongly 
agree that SOB affects physical activity. Overweight, obese and morbidly obese adults were 
significantly (p<0.05) less likely than adults with normal weight to be current smokers. In 
contrast, overweight and obese adults were significantly (p<0.05) more likely than adults 
with normal weight to be former smokers. A history of cancer did not differ by BMI level 
(Table 2). In an age-adjusted logistic regression model, only those who were underweight 
were more likely to have cancer compared to normal weight respondents (PR=1.66; 95% CI:
1.01-2.72); however, that relationship was no longer significant after adjustment for other 
covariates (data not shown).
U-shaped relationships of BMI levels with age-adjusted prevalence of COPD and current 
asthma history were demonstrated in Figure 2 and with the three respiratory symptoms in 
Figure 3.
The modest U-shaped relationships of BMI levels with current asthma and SOB affected 
physical activity persisted (p<0.001) after controlling for the covariates (Table 3). Obese or 
morbidly obese but not underweight respondents were still significantly more likely to have 
COPD than normal weight adults after adjustment for covariates. In addition, morbidly 
obese adults but not obese adults were still significantly more likely to have a frequent 
productive cough and frequent SOB than normal weight adults after the adjustment (Table 
3).
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Discussion
We examined the relationship of BMI with respiratory symptoms, current asthma, and 
COPD in a state-based health survey of nearly 12,000 adults who resided in SC in 2012. The 
data showed that persons who were at extremes of BMI (underweight, obese, or morbidly 
obese) had a higher prevalence of self-reported, provider-diagnosed current asthma and/or 
COPD than persons who were of normal weight. The frequency of respiratory symptoms 
also appeared to differ with BMI level. SOB affecting physical activities was reported most 
often among persons who were underweight (BMI ≤ 18.5 kg/m2) or morbidly obese (BMI ≥ 
40 kg/m2). Morbidly obese persons were also more likely to report frequent SOB than 
respondents with normal weight. The association of obese or morbidly obese with COPD is 
consistent to the results in previous studies [10-13], however, the relationship of 
underweight with asthma is a new finding. These associations persisted after adjustment for 
potential confounders, including age, sex, race/ethnicity, education, smoking status, physical 
activity, and a history of cancer.
The relationship of BMI and obstructive lung diseases is complex and has been extensively 
researched. One particularly important phenotype that has emerged from this research is the 
underweight COPD patient. It has been reported in some clinical studies that 12-25% of 
COPD patients are underweight or cachectic [21,22]. This occurs more frequently in 
advanced disease and is associated with a marked increase in mortality rates [23]. Several 
pathways that can result in COPD patients having low body weight include: 1) having 
baseline low body weight prior to developing COPD [24]; 2) developing low body weight 
due to COPD complications [25,26]; and 3) as observed in our study, a tendency for higher 
rates of current smoking among persons who are underweight and/or have COPD, which is 
consistent with observations from cross-sectional US surveys. One longitudinal study over a 
decade showed that men who have a low BMI have 2.7 fold higher risk of developing 
COPD compared to others [24]. In some COPD patients, advanced disease may lead to 
developing a low BMI from the substantial dyspnea, hypoxia, and inflammation, which 
further raises energy expenditure, decreases energy intake, and leads to nutritional depletion 
and weight loss [27]. In our study, underweight respondents reported SOB affecting physical 
activities more frequently, greater physical inactivity, asthma, and COPD than normal 
weight persons. We also found that persons with low BMI reported the highest rates of 
current smoking. Guerra et al have suggested that a low BMI is related to emphysema while 
obesity is related to chronic bronchitis [28]. However, our study could not address these 
relationships because of survey question limitations in the BRFSS. A recent analysis of 
COPDGene study subjects found that among the 4 different phenotypic clusters of COPD 
patients, the group with relatively low BMI had more extensive evidence of emphysema, 
more severe disease, and frequent exacerbations, and more extensive tobacco use intensity 
[29]. The group that had relatively high BMIs were more likely to be female, had 
predominantly airways disease, lower tobacco use intensity than the low BMI group, and 
relatively less emphysema [29]. Our underweight and morbidly obese subjects share some of 
these same characteristics. Little is published regarding interventions that are able to 
maintain higher body mass in these types of patients. Smoking cessation may be especially 
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important in this type of patient in order to slow progression of COPD and promote weight 
gain.
Another well-studied weight-related phenotype of obstructive lung disease is the obese 
asthmatic. Obesity is an important risk factor for both prevalent and incident asthma [8,30]. 
Our data also show higher asthma prevalence in obese persons; especially in the morbidly 
obese group where there was a three-fold higher rate compared to normal or overweight 
persons. Etiologies for higher rates of asthma in obesity include altered respiratory 
mechanics leading to an increased work of breathing, physical inactivity, increased 
inflammation, and altered responses to drug therapies [16]. Nearly one-half of the morbidly 
obese persons in our survey reported physical inactivity in the last month and frequent SOB 
was two times more likely to occur than in normal weight persons. Previous studies have 
suggested that obesity may increase the resistance of airway and decrease respiratory muscle 
endurance, and further cause dyspnea, wheezing, hypoxia [10,31,32], and even asthma 
[8,16]. In addition, obesity is also highly related to chronic and low-grade inflammation, 
which may contribute to the development of COPD [33]. Although greater dyspnea may be 
associated with obesity and over-diagnosis of asthma may occur, two studies have reported 
that over-diagnosis of asthma in the obese population is not observed to any greater extent 
than in non-obese persons [34,35]. Most studies have defined obese asthma patients as those 
with BMI ≥ 30 kg/m2 and few have compared obese and morbidly obese [18,30,36,37]. One 
study that included both obese and morbidly obese subjects showed that lung volumes were 
incrementally decreased as the BMI increased [38]. Obese and especially morbidly obese 
persons breath at low lung volumes and therefore are more likely to have more severe 
respiratory symptoms compared to non-obese persons. Subsequently, respiratory symptoms 
are often more likely to be reported in the obese asthmatic who has less severe airflow 
obstruction as measured by spirometry. Some studies report that obese or morbidly obese 
females are more likely to be diagnosed with asthma than males [28]. However, this is not 
true in another study [39]. Considering the higher prevalence of obesity in females in the 
general population, there may be a greater number of obese females with asthma. In our 
study population, nearly two-thirds of the morbidly obese group were female, nearly one-
half were African American, and frequent SOB was 2 times more likely among morbidly 
obese than normal weight persons. Although severe disease occurs in less than 10% of all 
asthmatics, one study reported a third of severe asthmatics required chronic oral 
corticosteroid use [40]. Chronic systemic steroid use and associated weight gain could 
contribute to obesity in asthma. Bariatric surgery in morbidly obese persons has led to 
decreased airway hyperreactivity, improved lung volumes, and lessened asthma severity 
[41]. The role of pulmonary rehabilitation in obese COPD patients has been studied and 
compared to lower weight COPD such that obese subjects present with less severe 
impairment in pulmonary function tests and poorer exercise performance, but outcomes 
associated with pulmonary rehabilitation are similar in obese and non-obese persons [42]. 
Another study examining the effects of pulmonary rehabilitation on obese COPD subjects 
showed improvement in some measures such as quality of life, but not 6-minute walk test 
[43].
Unlike the COPD population, relatively few studies have reported that low BMI affects the 
prevalence or severity of asthma [44]. We found that underweight persons were two times as 
Liu et al. Page 7
Respir Med. Author manuscript; available in PMC 2016 July 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
likely to report asthma as were normal or over-weight persons. Schatcher also reported a U-
shaped relationship for asthma where low and very high BMI led to worse asthma symptoms 
as well as increased airway hyper-responsiveness in low BMI, but not morbidly obese BMI 
[18]. One study in China reported more severe asthma in low BMI persons [8] and another 
study in children reported relatively severe asthma in those who were underweight [45]. 
Therefore, additional studies are needed to explore the relationship between low BMI and 
asthma prevalence and severity.
The link between obesity and COPD has become more widely recognized. We found that 
the morbidly obese group reported the highest prevalence of COPD compared to all groups 
except the underweight group. Steuten et al and Eisner reported a higher prevalence of 
obesity in GOLD stage I and II than in the general population [46,47]. Both of these studies 
reported that obesity was more likely to be present in mild to moderate than severe COPD. 
The classic clinical COPD phenotype including “blue bloater” has typically been associated 
with chronic bronchitis in overweight persons [48]. The Tucson prospective cohort study of 
obstructive lung diseases showed a higher prevalence of chronic bronchitis in persons with a 
BMI ≥ 28 kg/m2 [28]. Although frequent productive cough was reported more frequently in 
the morbidly obese persons in our study, this was not statistically different.
The strength of this study is the relatively large sample of adult, which allowed analysis of 
relationship of BMI particularly among underweight or morbidly obese respondents with 
respiratory symptoms and respiratory conditions. A few prior population studies reported 
similar findings only among obese adults [32,49]. However, this study has some limitations. 
First, the BRFSS survey is a cross-sectional study; therefore causal relationships of BMI 
with respiratory symptoms and respiratory conditions cannot be established. Second, the 
analyses relied upon self-reported information from telephone interviews and could not be 
validated with medical record data. Finally, our results, which were obtained from 
households, were only representative of the non-institutionalized population in SC. Persons 
with more severe COPD and respiratory symptoms may be more likely to be residing in 
nursing homes; therefore the observed relationship may be underestimated. However, 
because the BRFSS appears to be a useful tool to describe the relationship between BMI and 
obstructive lung diseases, implementation and analysis of these questions in other states 
would help confirm our findings.
Conclusion
We observed that both underweight and obesity are associated with asthma and obesity with 
COPD from one state population data. In addition, underweight respondents reported much 
higher respiratory symptoms and respiratory conditions. Providing nutritional and smoking 
cessation counseling may help to improve respiratory symptoms and respiratory conditions.
References
1. Carey IM, Cook DG, Strachan DP. The effects of adiposity and weight change on forced expiratory 
volume decline in a longitudinal study of adults. Int J Obes Relat Metab Disord. 1999; 23:979–985. 
[PubMed: 10490805] 
Liu et al. Page 8
Respir Med. Author manuscript; available in PMC 2016 July 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
2. Chen Y, Horne SL, Dosman JA. Body weight and weight gain related to pulmonary function decline 
in adults: a six year follow up study. Thorax. 1993; 48:375–380. [PubMed: 8511735] 
3. Chinn DJ, Cotes JE, Reed JW. Longitudinal effects of change in body mass on measurements of 
ventilatory capacity. Thorax. 1996; 51:699–704. [PubMed: 8882076] 
4. Kannel WB, Cupples LA, Ramaswami R, Stokes J III, Kreger BE, Higgins M. Regional obesity and 
risk of cardiovascular disease: The Framingham Study. J Clin Epidemiol. 1991; 44:183–190. 
[PubMed: 1995775] 
5. Ray CS, Sue DY, Bray G, Hansen JE, Wasserman K. Effects of obesity on respiratory function. Am 
Rev Respir Dis. 1983; 128:501–506. [PubMed: 6614644] 
6. Thomas PS, Cowen ER, Hulands G, Milledge JS. Respiratory function in the morbidly obese before 
and after weight loss. Thorax. 1989; 44:382–386. [PubMed: 2503905] 
7. Subhan MM, Ali SA, Bokhari SS, Khan MN, Ahmad HR. Underweight and overweight men have 
greater exercise-induced dyspnea than normal weight men. Upsala J Med Sci. 2012; 117:383–389. 
[PubMed: 22931098] 
8. Celedon JC, Palmer LJ, Litonjua AA, et al. Body mass index and asthma in adults in families of 
subjects with asthma in Anqing, China. Am J Respir Crit Care Med. 2001; 164(Pt 1):1835–1840. 
[PubMed: 11734432] 
9. Yamaguchi Y, Hibi S, Ishii M, et al. Pulmonary features associated with being underweight in older 
men. J Am Geriatr Soc. 2011; 59:1558–1560. [PubMed: 21848827] 
10. Gibson GJ. Obesity, respiratory function and breathlessness. Thorax. 2000; 55(Suppl 1):S41–S44. 
[PubMed: 10943638] 
11. Franssen FME, O'Donnell DE, Goossens GH, Blaak EE, Schols AMWJ. Obesity and the lung: 5 
obesity and COPD. Thorax. 2008; 63:1110–1117. [PubMed: 19020276] 
12. Ora J, Laveneziana P, Ofir D, Deesomchok A, Webb KA, O'Donnell DE. Combined effects of 
obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance. Am J Respir 
Crit Care Med. 2009; 180:964–971. [PubMed: 19897773] 
13. O'Donnell DE, O'Donnell CDJ, Webb KA, Guenette JA. Respiratory consequences of mild-to-
moderate obesity: impact on exercise performance in health and in chronic obstructive pulmonary 
disease. Pulmonary Med. 2012; 2012 818925 (http://dx.doi.org/10.1155/2012/818925). 
14. Zutler M, Singer JP, Omachi TA, et al. Relationship of obesity with respiratory symptoms and 
decreased functional capacity in adults without established COPD. Prim Care Respir J. 2012; 
21:194–201. [PubMed: 22453663] 
15. Chinn S, Jarvis D, Burney P. Relation of bronchial responsiveness to body mass index in the 
ECRHS. European Community Respiratory Health Survey. Thorax. 2002; 57:1028–1033. 
[PubMed: 12454296] 
16. Dixon AE, Holguin F, Sood A, et al. An official American Thoracic Society Workshop report: 
obesity and asthma. Proc Am Thorac Soc. 2010; 7:325–335. [PubMed: 20844291] 
17. Bustos P, Amigo H, Oyarzún M, Rona RJ. Is there a causal relation between obesity and asthma? 
Evidence from Chile. Int J Obes (Lond). 2005; 29:804–809. [PubMed: 15824747] 
18. Schachter LM, Salome CM, Peat JK, Woolcock AJ. Obesity is a risk for asthma and wheeze but 
not airway hyperresponsiveness. Thorax. 2001; 56:4–8. [PubMed: 11120896] 
19. Sin DD, Jones RL, Man SFP. Obesity is a risk factor for dyspnea but not for airflow obstruction. 
Arch Intern Med. 2002; 62:1477–1481. [PubMed: 12090884] 
20. O'Donnell DE, Deesomchok A, Lam Y-M, et al. Effects of BMI on static lung volumes in patients 
with airway obstruction. Chest. 2011; 40:461–468. [PubMed: 21310838] 
21. Congleton J. The pulmonary cachexia syndrome: aspects of energy balance. Proc Nutr Soc. 1999; 
8:321–328. [PubMed: 10466173] 
22. Van den Bemt L, Smeele IJ, Kolkman M, Grol M, van Weel C, Schermer TR. Low body mass 
index, airflow obstruction, and dyspnea in a primary care COPD patient population. Prim Care 
Respir J. 2010; 19:118–123. [PubMed: 20082060] 
23. Wilson DO, Rogers RM, Wright EC, Anthonisen NR. Body weight in Chronic Obstructive 
Pulmonary Disease: The National Institutes of Health Intermittent Positive-Pressure Breathing 
Trial. Am Rev Respir Dis. 1989; 139:1435–1438. [PubMed: 2658702] 
Liu et al. Page 9
Respir Med. Author manuscript; available in PMC 2016 July 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
24. Harik-Khan RI, Fleg JL, Wise RA. Body mass index and risk of COPD. Chest. 2002; 21:370–376. 
[PubMed: 11834645] 
25. Agusti AG, Noguera A, Sauleda J, Sala E, Pons J, Busquets X. Systemic effects of chronic 
obstructive pulmonary disease. Eur Respir J. 2003; 1:347–360. [PubMed: 12608452] 
26. Schols AM, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis 
of chronic obstructive pulmonary disease. Am J Respir Care Med. 1998; 157(Pt 1):1791–1797.
27. Decramer M, De Benedetto F, Del Ponte A, Marinari S. Systemic effects of COPD. Respir Med. 
2005; 99(Suppl B):S3–S10. [PubMed: 16219454] 
28. Guerra S, Sherrill DL, Bobadilla A, Martinez FD, Barbee RA. The relation of body mass index to 
asthma, chronic bronchitis, and emphysema. Chest. 2002; 122:1256–1263. [PubMed: 12377850] 
29. Castaldi PJ, Dy J, Ross R, et al. Cluster analysis in the COPDGene study identifies subtypes of 
smokers with distinct patterns of airways disease and emphysema. Thorax. 2014; 69:415–422. 
[PubMed: 24563194] 
30. Ford ES. The epidemiology of obesity and asthma. J Allergy Clin Immunol. 2005; 115(5):897–
909. [PubMed: 15867841] 
31. Babb TG, Ranasinghe KG, Comeau LA, Semon TL, Schwartz B. Dyspnea on exertion in obese 
women: association with an increased oxygen cost of breathing. Am J Respir Crit Care Med. 2008; 
178:116–123. [PubMed: 18420968] 
32. Wannamethee SG, Shaper AG, Whincup PH. Body fat distribution, body composition, and 
respiratory function in elderly men. Am J Clin Nutr. 2005; 82:996–1003. [PubMed: 16280430] 
33. Zammit C, Liddicoat H, Moonsie I, Makker H. Obesity and respiratory diseases. Int J Gen Med. 
2010; 3:335–343. [PubMed: 21116339] 
34. Pakhale S, Doucette S, Vandemmeem K, et al. Comparison of obese and non-obese people with 
asthma: exploring an asthma/obesity interaction. Chest. 2010; 137:1316–1323. [PubMed: 
20154078] 
35. van Huisstede A, Cabezas MC, van de Geijn GM, et al. Underdiagnosis and overdiagnosis of 
asthma in the morbidly obese. Respir Med. 2013; 107:1356–1364. [PubMed: 23764128] 
36. Al-Alwan A, Bates JH, Chapman DG, et al. The nonallergic asthma of obesity. A matter of distal 
lung compliance. Am J Respir Crit Care Med. 2014; 189:1494–1502. [PubMed: 24821412] 
37. Mahadev S, Salome CM, Berend N, King GG. The effect of low lung volume on airway function 
in obesity. Respir Physiol Neurobiol. 2013; 188:192–199. [PubMed: 23770312] 
38. Jones RL, Nzekwu MM. The effects of body mass index on lung volumes. Chest. 2006; 130:827–
833. [PubMed: 16963682] 
39. Beuther DA, Sutherland ER. Overweight, obesity, and incident asthma: a meta-analysis of 
prospective epidemiologic data. Am J Respir Crit Care Med 1. 2007; 75:661–666.
40. Moore WC, Bleecker ER, Curran-Everett D, et al. Characterization of the severe asthma phenotype 
by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy 
Clin Immunol. 2007; 119:405–413. [PubMed: 17291857] 
41. Boulet LP, Turcotte H, Martin J, Poirier P. Effect of bariatric surgery on airway response and lung 
function in obese subjects with asthma. Respir Med. 2012; 106:651–660. [PubMed: 22326605] 
42. Ramachandran K, McCusker C, Connors M, Zuwallack R, Lahiri B. The influence of obesity on 
pulmonary rehabilitation outcomes in patients with COPD. Chronic Respir Dis. 2008; 5:205–209.
43. Sava F, Laviolette L, Bernard S, Breton M, Bourbeau J, Maltais F. The impact of obesity on 
walking and cycling performance and response to pulmonary rehabilitation in COPD. BMC 
Pulmonol Med. 2010; 10:55.
44. Akerman MJ, Calacanis CM, Madsen MK. Relationship between asthma severity and obesity. J 
Asthma. 2004; 41:521–526. [PubMed: 15360059] 
45. Chu YT, Chen WY, Wang TN, Tseng HI, Wu JR, Ko YC. Extreme BMI predicts higher asthma 
prevalence and is associated with lung function impairment in school-aged children. Pediatric 
Pulmonol. 2009; 44:472–479.
46. Eisner MD, Blanc PD, Sidney S, et al. Body composition and functional limitation in COPD. 
Respir Res. 2007; 8:7. [PubMed: 17261190] 
Liu et al. Page 10
Respir Med. Author manuscript; available in PMC 2016 July 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
47. Steuten LM, Creutzberg EC, Vrijhoef HJ, Wouters EF. COPD as a multicomponent disease: 
inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care. Prim 
Care Respir J. 2006; 15:84–91. [PubMed: 16701766] 
48. Filley GF, Buckwitt HJ, Reeves JT. Chronic obstructive bronchopulmonary disease. II Oxygen 
transport in two clinical types. Am J Med. 1968; 44:26–38. [PubMed: 5635286] 
49. Canoy D, Luben R, Welch A, et al. Abdominal obesity and respiratory function in men and women 
in the EPIC-Norfolk Study, United Kingdom. Am J Epidemiol. 2004; 159:1140–1149. [PubMed: 
15191931] 
Abbreviations
COPD chronic obstructive pulmonary disease
BRFSS Behavioral Risk Factor Surveillance System
SOB short of breath
BMI Body Mass Index
Liu et al. Page 11
Respir Med. Author manuscript; available in PMC 2016 July 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 1. Distribution of levels of body mass index among adults aged ≥18 years by chronic 
obstructive pulmonary disease and current asthma status: South Carolina, 2012
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Figure 2. Age-adjusted prevalence of chronic obstructive pulmonary disease and current asthma 
among adults aged ≥18 years, by level of body mass index: South Carolina, 2012
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Figure 3. Age-adjusted percentage of frequent productive cough, frequent shortness of breath 
(SOB), and strong agreement that SOB affects physical activity among adults aged ≥18 years, by 
level of body mass index: South Carolina, 2012
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Table 1
The distribution of selected characteristics among 11,868 adults aged ≥18 years: South 
Carolina, 2012
Characteristic Na % (95% CI)b
Sex
 Men 4,777 49.5 (48.2-50.8)
 Women 7,091 50.5 (49.2-51.8)
Age (years)
 18-24 590 13.2 (12.1-14.4)
 25-34 1,115 16.6 (15.6-17.8)
 35-44 1,402 16.4 (15.4-17.5)
 45-64 4,654 34.5 (33.3-35.7)
 65+ 4,107 19.2 (18.4-20.1)
Race
 Non-Hispanic White 7,983 66.8 (65.5-68.1)
 Non-Hispanic Black 3,291 25.6 (24.4-26.7)
 Other/multiracial 594 7.6 ( 6.8- 8.6)
Education
 Less than high school diploma 1,391 16.3 (15.1-17.5)
 High school graduate or equivalent 3,714 30.8 (29.5-32.0)
 At least some college 6,763 53.0 (51.6-54.3)
Smoking status
 Current smokers 2,054 23.0 (21.8-24.2)
 Former smokers 3,501 25.9 (24.8-27.0)
 Never smokers 6,110 51.1 (49.8-52.5)
Physical inactivity in past month 3,184 24.4 (23.3-25.6)
Body Mass Index (BMI, kg/m2)
 Underweight (<18.5) 184 1.5 ( 1.2- 1.9)
 Normal weight (18.5-24.9) 3,639 32.3 (31.0-33.6)
 Overweight (25.0-29.9) 4,255 34.6 (33.3-35.9)
 Obese (30.0-39.9) 3,146 26.5 (25.4-27.7)
 Morbidly obese (≥40.0) 644 5.1 ( 4.6- 5.7)
Chronic Conditions
 Any cancer excluding skin cancer 1,184 6.6 ( 6.1- 7.2)
 Current asthma 942 8.4 ( 7.7- 9.2)
 Chronic obstructive pulmonary disease 1,033 7.4 ( 6.7- 8.1)
Frequent productive cough 1,173 10.0 (9.2-10.8)
Frequent shortness of breath (SOB) 518 4.3 ( 3.8- 4.9)
Strongly agree that shortness of breath affects physical activity 890 7.3 ( 6.6- 8.0)
aUnweighted sample size.
bWeighted percentage and 95% confidence interval (CI).
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Table 3
Age-adjusted prevalence and adjusted likelihood of having respiratory symptoms and 
respiratory conditions associated with level of body mass index among adults aged ≥18 
years: South Carolina, 2012
Body Mass Index (kg/m2)
Age-adjusted prevalence Model 1 Model 2
% (95% CI) Adjusted prevalence ratio (95% CI)
Adjusted prevalence ratio 
(95% CI)
Chronic Obstructive Pulmonary Disease (COPD)
 Underweight (<18.5) 13.1 ( 7.6-18.6) 1.55 (1.00-2.41) 1.49 (0.95-2.32)
 Normal weight (18.5-24.9) 6.7 ( 5.6- 7.8) 1.00 (referent) 1.00 (referent)
 Overweight (25.0-29.9) 5.7 ( 4.7- 6.7) 0.93 (0.73-1.18) 0.92 (0.73-1.17)
 Obese (30.0-39.9) 8.5 ( 7.2- 9.9) 1.30 (1.03-1.64) 1.29 (1.02-1.64)
 Morbidly obese (≥40.0) 15.4 (11.4-19.4) 2.25 (1.65-3.08) 2.22 (1.62-3.04)
Current Asthma
 Underweight (<18.5) 13.8 ( 6.2-21.3) 2.15 (1.22-3.81) 2.13 (1.21-3.76)
 Normal weight (18.5-24.9) 5.8 ( 4.6- 6.9) 1.00 (referent) 1.00 (referent)
 Overweight (25.0-29.9) 6.4 ( 5.3- 7.5) 1.18 (0.91-1.53) 1.17 (0.90-1.52)
 Obese (30.0-39.9) 11.8 ( 9.9-13.7) 1.99 (1.53-2.57) 1.98 (1.53-2.57)
 Morbidly obese (≥40.0) 18.8 (14.3-23.4) 2.86 (2.08-3.93) 2.84 (2.06-3.91)
Frequent productive cough
 Underweight (<18.5) 14.6 ( 8.5-20.7) 1.40 (0.91-2.13) 1.36 (0.88-2.08)
 Normal weight (18.5-24.9) 9.0 ( 7.7-10.4) 1.00 (referent) 1.00 (referent)
 Overweight (25.0-29.9) 8.9 ( 7.6-10.2) 1.04 (0.84-1.27) 1.03 (0.84-1.27)
 Obese (30.0-39.9) 9.2 ( 7.7-10.6) 1.05 (0.84-1.31) 1.04 (0.83-1.31)
 Morbidly obese (≥40.0) 13.4 ( 9.6-17.2) 1.54 (1.11-2.13) 1.52 (1.10-2.11)
Frequent shortness of breath (SOB)
 Underweight (<18.5) 6.9 ( 2.1-11.7) 1.48 (0.73-2.99) 1.39 (0.70-2.77)
 Normal weight (18.5-24.9) 3.6 ( 2.7- 4.5) 1.00 (referent) 1.00 (referent)
 Overweight (25.0-29.9) 2.7 ( 2.0- 3.4) 0.79 (0.55-1.14) 0.79 (0.55-1.13)
 Obese (30.0-39.9) 4.9 ( 3.9- 6.0) 1.20 (0.87-1.67) 1.20 (0.87-1.65)
 Morbidly obese (≥40.0) 10.2 ( 7.0-13.5) 2.20 (1.43-3.37) 2.13 (1.39-3.29)
Strongly agree that SOB affects physical activity
 Underweight (<18.5) 19.0 ( 9.6-28.5) 2.78 (1.65-4.67) 2.68 (1.57-4.57)
 Normal weight (18.5-24.9) 5.6 ( 4.4- 6.8) 1.00 (referent) 1.00 (referent)
 Overweight (25.0-29.9) 4.7 ( 3.9- 5.5) 0.85 (0.66-1.11) 0.85 (0.65-1.10)
 Obese (30.0-39.9) 9.0 ( 7.6-10.3) 1.38 (1.07-1.79) 1.38 (1.07-1.78)
 Morbidly obese (≥40.0) 13.7 (10.1-17.2) 1.91 (1.33-2.74) 1.87 (1.30-2.69)
Model 1: a multivariable logistic regression model that includes sex, age, race/ethnicity, education, smoking status, and any exercise as covariates 
in addition to body mass index;
Model 2: a multivariable logistic regression model that includes history of cancer (excluding skin cancer) in addition to covariates in model 1;
Respir Med. Author manuscript; available in PMC 2016 July 01.
